265 related articles for article (PubMed ID: 31069869)
1. CADM1 associates with Hippo pathway core kinases; membranous co-expression of CADM1 and LATS2 in lung tumors predicts good prognosis.
Ito T; Nakamura A; Tanaka I; Tsuboi Y; Morikawa T; Nakajima J; Takai D; Fukayama M; Sekido Y; Niki T; Matsubara D; Murakami Y
Cancer Sci; 2019 Jul; 110(7):2284-2295. PubMed ID: 31069869
[TBL] [Abstract][Full Text] [Related]
2. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
[TBL] [Abstract][Full Text] [Related]
3. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
4. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
Suh JH; Won KY; Kim GY; Bae GE; Lim SJ; Sung JY; Park YK; Kim YW; Lee J
Int J Clin Exp Pathol; 2015; 8(11):14608-18. PubMed ID: 26823784
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
[TBL] [Abstract][Full Text] [Related]
6. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
[TBL] [Abstract][Full Text] [Related]
7. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
Guo C; Wang X; Liang L
Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
9. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
[TBL] [Abstract][Full Text] [Related]
10. YAP1-LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis.
He C; Lv X; Huang C; Hua G; Ma B; Chen X; Angeletti PC; Dong J; Zhou J; Wang Z; Rueda BR; Davis JS; Wang C
EMBO Rep; 2019 Mar; 20(3):. PubMed ID: 30755404
[TBL] [Abstract][Full Text] [Related]
11. Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma.
Jang SH; Oh MH; Cho H; Lee JH; Lee H; Ahn H; Kim H
Pol J Pathol; 2019; 70(3):189-197. PubMed ID: 31820862
[TBL] [Abstract][Full Text] [Related]
12. The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl.
Reuven N; Adler J; Meltser V; Shaul Y
Cell Death Differ; 2013 Oct; 20(10):1330-40. PubMed ID: 23852372
[TBL] [Abstract][Full Text] [Related]
13. microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors.
Aguennouz M; Polito F; Visalli M; Vita G; Raffa G; Oteri R; Ghazi B; Scalia G; Angileri FF; Barresi V; Caffo M; Cardali S; Conti A; Macaione V; Bartolotta M; Giorgio RD; Germanò A
Cancer Treat Res Commun; 2020; 24():100203. PubMed ID: 32777750
[TBL] [Abstract][Full Text] [Related]
14. Hippo pathway and tumoral FOXP3 expression correlate with tumor growth in squamous cell carcinoma of the lung.
Won KY; Kim HK; Kim GY; Song MJ; Lim SJ
Pathol Res Pract; 2020 Jul; 216(7):153003. PubMed ID: 32534707
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
[TBL] [Abstract][Full Text] [Related]
16. CADM1 is a TWIST1-regulated suppressor of invasion and survival.
Hartsough EJ; Weiss MB; Heilman SA; Purwin TJ; Kugel CH; Rosenbaum SR; Erkes DA; Tiago M; HooKim K; Chervoneva I; Aplin AE
Cell Death Dis; 2019 Mar; 10(4):281. PubMed ID: 30911007
[TBL] [Abstract][Full Text] [Related]
17. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
Yan R; Liang ZW; Liu HS; Ge Y; An GY
Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
[No Abstract] [Full Text] [Related]
18. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.
Feng S; Sun H; Zhu W
Clin Transl Oncol; 2021 Mar; 23(3):450-458. PubMed ID: 32654106
[TBL] [Abstract][Full Text] [Related]
19. Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.
Luo SY; Sit KY; Sihoe AD; Suen WS; Au WK; Tang X; Ma ES; Chan WK; Wistuba II; Minna JD; Tsao GS; Lam DC
Lung Cancer; 2014 Aug; 85(2):282-92. PubMed ID: 24976335
[TBL] [Abstract][Full Text] [Related]
20.
Li L; Dong L; Wang Y; Zhang X; Yan J
Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]